2m 2m 2m 2m 2m 2m 2m
SCHOLAR RCK HLDG (SRRK)
NASDAQ
$49.77+$0.58 (+1.19%)
Price as of Jun 23, 2026 9:36 AM EDT- $5.9BMarket Cap
- 47.81%1-Year Change
- BiotechnologyIndustry
SCHOLAR RCK HLDG (SRRK)
$49.77+$0.58 (+1.19%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 33.2M 0.00% | 33.2M +76.41% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 33.2M 0.00% | 33.2M +76.41% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -208.4M +12.95% | -184.6M +51.39% | -121.9M -2.04% | -124.4M +14.73% | |
Depreciation and Amortization Expense | 1.7M -14.40% | 1.9M -31.89% | 2.8M -4.76% | 3.0M +13.67% | |
Total Operating Expenses | 384.6M +52.60% | 252.1M +47.15% | 171.3M +2.23% | 167.6M +12.66% | |
Operating Profit | -384.6M +52.60% | -252.1M +47.15% | -171.3M +27.48% | -134.4M +3.42% | |
Interest Income | 13.9M +9.60% | 12.7M N/A | N/A N/A | N/A N/A | |
Interest Expense | -6.3M -4.55% | -6.6M +1.54% | -6.5M +38.30% | -4.7M +123.81% | |
Interest Income and Expense and Net | 7.6M +24.96% | 6.1M +193.57% | -6.5M +38.30% | -4.7M +123.81% | |
Total Nonoperating Income and Expense | 6.7M +16.42% | 5.8M +4.61% | 5.5M +4,271.21% | -132,000 -92.97% | |
Income before Taxes | -384.6M +52.60% | -252.1M +47.15% | -171.3M +27.48% | -134.4M +3.42% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -377.9M +53.45% | -246.3M +48.56% | -165.8M +23.26% | -134.5M +2.05% | |
Net Income from Continuing Operations Applicable to Common | -377.9M +53.45% | -246.3M +48.56% | -165.8M +23.26% | -134.5M +2.05% | |
Basic EPS and Net Income | -3.29 +33.20% | -2.47 +24.12% | -1.99 -11.95% | -2.26 -37.05% | |
Diluted EPS and Net Income | -3.29 +33.20% | -2.47 +24.12% | -1.99 -11.95% | -2.26 -37.05% | |
Basic Weighted Average Shares | 114.7M +14.89% | 99.8M +19.79% | 83.3M +39.82% | 59.6M +62.38% | |
Diluted Weighted Average Shares | 114.7M +14.89% | 99.8M +19.79% | 83.3M +39.82% | 59.6M +62.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 323.5M +81.88% | 177.9M +74.64% | 101.9M -1.37% | 103.3M -51.48% | |
Short-Term Investments | 44.0M -83.02% | 259.4M +45.66% | 178.1M -16.03% | 212.1M +428.12% | |
Cash and Cash Equivalents and Short-Term Investments | 367.6M -15.94% | 437.3M +56.21% | 279.9M -11.23% | 315.4M +24.65% | |
Total Current Assets | 385.1M -14.63% | 451.2M +56.55% | 288.2M -12.14% | 328.0M +23.63% | |
Accumulated Depreciation | 14.9M +12.54% | 13.2M +16.70% | 11.3M +10.70% | 10.2M +40.32% | |
Property and Plant and Equipment and Net | 1.7M -38.25% | 2.8M -39.98% | 4.6M -37.70% | 7.4M -22.79% | |
Total Long-Term Assets | 3.2M +9.71% | 2.9M -33.33% | 4.4M +156.95% | 1.7M +5.98% | |
Total Assets | 404.3M -14.88% | 474.9M +52.69% | 311.0M -13.16% | 358.2M +17.65% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 1.3M 0.00% | 1.3M -15.41% | 1.6M 0.00% | |
Total Current Liabilities | 55.4M +18.07% | 46.9M +43.36% | 32.7M -10.03% | 36.4M -43.40% | |
Total Long-Term Debt | 99.7M +98.84% | 50.1M +3.00% | 48.7M -2.13% | 49.7M +2.73% | |
Total Long-Term Liabilities | 103.4M +74.16% | 59.4M +11.82% | 53.1M -13.76% | 61.5M +1,230,780.00% | |
Total Liabilities | 158.8M +49.39% | 106.3M +23.85% | 85.8M -12.37% | 97.9M -26.02% | |
Retained Earnings | -1.3B +40.96% | -922.7M +36.41% | -676.4M +32.47% | -510.6M +35.76% | |
Total Stockholders Equity | 245.5M -33.41% | 368.6M +63.68% | 225.2M -13.46% | 260.2M +51.23% | |
Total Shares Outstanding | 108.5M +15.60% | 93.8M +23.49% | 76.0M +47.04% | 51.7M +46.76% | |
Cash Flow | |||||
Cash from Operating Activities | -300.0M +49.31% | -200.9M +38.37% | -145.2M +9.44% | -132.7M +4.66% | |
Capital Expenditures | 602,000 +514.29% | 98,000 +38.03% | 71,000 -93.33% | 1.1M -79.73% | |
Cash from Investing Activities | 218.7M +387.53% | -76.1M -284.87% | 41.1M +123.96% | -171.7M -227.83% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 228.4M -35.30% | 353.0M +244.17% | 102.6M -47.35% | 194.8M +333.43% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | -516.06% +27.48% | -404.81% -41.37% | |
Return on Assets | -85.97% +37.18% | -62.67% +26.49% | -49.55% +22.05% | -40.60% +6.69% | |
Return on Equity | -123.08% +48.39% | -82.95% +21.44% | -68.30% +9.77% | -62.22% +2.18% | |
Revenue Growth | N/A N/A | N/A N/A | 0.00% -100.00% | 76.41% +244.83% | |
Current Ratio | 6.95 -27.70% | 9.61 +9.20% | 8.80 -2.35% | 9.01 +118.45% | |
Cash Ratio | 5.84 +54.04% | 3.79 +21.82% | 3.11 +9.61% | 2.84 -14.26% | |
Debt-to-Equity Ratio | N/A N/A | 0.14 -37.10% | 0.22 +12.63% | 0.20 -32.14% | |
Debt-to-Assets Ratio | N/A N/A | 0.11 -32.59% | 0.16 +12.21% | 0.14 -12.73% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow